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Research Article
pH-regulated formation of side products
in the reductive amination approach for
differential labeling of peptides in relative
quantitative experiments
Among the most common stable-isotope labeling strategies, the reaction of formalde-
hyde with peptides in the presence of NaCNBH3 features many attractive aspects that
are conducive to its employment in quantitation experiments in proteomics. Reductive
amination, with formaldehyde and d(2)-formaldehyde, is reported to be a fast, easy, and
specific reaction, undoubtedly inexpensive if compared with commercially available kits
for differential isotope coding. Acetaldehyde and d(4)-acetaldehyde could be employed as
well without a substantial increase in terms of cost, and should provide a wider spacing be-
tween the differentially tagged peptides in the mass spectrum. Nevertheless, only a single
paper reports about a diethylation approach for quantitation. We undertook a systematic
analytical investigation on the reductive amination of some standard peptides pointing
out the occasional occurrence of side reactions in dependence of pH or reagents order
of addition, particularly observing the formation of cyclic adducts ascribable to rearrange-
ments involving the generated Schiff-base and all the nucleophilic sites of its chemical
environment. We also tried to evaluate how much this side-products amount may impair
isotope coded relative quantitation.
Keywords:
Diethylation / Dimethylation / Quantitative analysis / Reductive amination / Stable
isotope labeling DOI 10.1002/elps.201300484
 Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site
1 Introduction
One of the most crucial issues and growing areas of mod-
ern proteomics is the relative quantification of the differen-
tial expression of proteins in two or more samples repre-
senting various conditions of biological systems. The sta-
ble isotope labeling techniques developed in the last two
decades for relative quantitation experiments space from in
vivometabolic incorporation of heavy isotopes, or isotopically
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imental Medicine, University “Tor Vergata,” Via Montpellier 1,
Rome 00133, Italy.
E-mail: stefano.levi.mortera@uniroma2.it
Fax: +396501703332
Abbreviations: ACTH, adrenocorticothropic hormone frag-
ment 18–39; EM, exact mass; FA, formic acid; HCCA, -cyano-
4-hydroxycinnamic acid; 2MEGA, dimethylation guanid-
ination; NaOAc, sodium acetate; TDP, renin substrate
tetradecapeptide human; TEAB, triethylammoniumbicarbon-
ate; TEAOAc, tetraethylammonium acetate
labeled aminoacids [1,2], to in vitro experiments with chemi-
cal reagents [3–6]. Many recent reviews give a comprehensive
picture of the current tendency for relative quantitative pro-
teomics with stable isotope labeling [7–11].
Reductive amination with formaldehyde and NaCNBH3
is a simple reaction that involves all the free amino groups
of peptides, namely N-termini and lysine residues, replacing
hydrogens with twomethyl groups [12]. A differential isotope
labeling can be achieved by employing d(0)-formaldehyde
and d(2)-formaldehyde obtaining a mass increment of 28
and 32 Da, respectively, for each derivatized reactive site.
Acetaldehyde and d(4)-acetaldehyde are still relatively inex-
pensive reagents and can be used as diethylating agents, by
the same approach, providing a wider separation, in terms of
mass units, between the differentially labeled peptides [13].
The chemistry of both formaldehyde and acetaldehyde
in biological systems features interesting aspects for pro-
teomics investigations. Formaldehyde has been widely used
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to fix tissues and cells and it is known as a cross-linking agent
involving a wide set of amino acid residues [14,15]. Metz et al.
reported a systematic investigation on a series of synthetic
peptides in the presence of glycine or NaCNBH3 [16, 17].
When the reducing agent is added to the mixture after
24 h incubation with formaldehyde, besides the expected di-
methylated peptide a secondary product featuring 2 mass
units less can be observed whereas a Schiff-base is generated
at the N-termini. According to earlier observations on ac-
etaldehyde, this side product can be traced to an intramolecu-
lar rearrangement that leads to the formation of a N-methyl-
4-imidazolidinone derivative, producing a mass increase of
26 Da instead of 28 [18–20].
Themild reducing agent,NaCNBH3, is known to bemore
selective and efficient towards protonated imines and, differ-
ently from NaBH4, can be used at acidic pH [21]. Jentoft
and Dearborn demonstrated that the effect of pH on the
reaction is more evident in case of short incubation time,
with an increase in the extent of labeling in basic environ-
ments [12]. Hsu et al. were the first to report the successful
application of dimethylation on peptides with a really short
reaction time (5 min) and a quantitative yield using an acidic
buffer (sodium acetate pH 5–6) [22]. In other papers Ji et al.
adopted the same conditions, increasing the incubation time
up to 1 h, while in the dimethylation after lysine guanidi-
nation approach (2MEGA), the reductive amination step is
carried on at pH 8 after guanidination of lysine residues at
pH 11 [23, 24]. Li et al. performed the dimethylation in wa-
ter with a short reaction time, adding formaldehydes prior to
NaCNBH3, reporting of a side product observedwhen extend-
ing the incubation time [25]. In another paper they also men-
tion negligible effects of buffer change in the range between
pH 3.0 and 8.2, in a systematic investigation with formalde-
hyde [26]. Boersema et al. in their recent protocol for triplex
experiments with formaldehydes isotopomers, recommend
to work in the pH range between 5 and 8.5, while She et al.
use a pH 8.5 buffer for reductive dimethylation, generating
formaldehydes in situ from paraformaldehydes before the
addition of the reducing agent [27, 28].
Negligible isotopic effect in HPLC runs has been verified
by Hsu and afterwards by other authors anyway reporting ex-
amples concerning the elution of only a single chosenpeptide.
Boutilier et al. recently published a more detailed investiga-
tion confirming a minimum chromatographic resolution for
the majority of eluted peptide pairs [29].
Barrios-Llerena et al. have recently published a novel la-
beling strategy based on diethylation employing acetaldehyde
and its isotopomers bearing 2H or 13C. The derivatization is
carried on at pH 6.6 with longer incubation time, with re-
spect to methylation. They performed quantitation only with
12C/13C labeling that ensures negligible isotopic chromato-
graphic effect [13]. As far as we know no earlier application
of diethylation labeling have been reported except for a re-
cent work about determination of monoamine neurotrans-
mitters [30].
On the base of a slight variability in protocols, in terms of
pH and reaction time, we decided to perform a series of tests
on some commercially available peptides before undertaking
experiments on complex biological samples, aiming at deter-
mine a reliable procedure. From our earlier observation with
both formaldehyde and acetaldehyde we noticed that, partic-
ularly in the diethylation approach, the occurrence of side
products is not unlikely at basic pH, even in the presence of
a preexistent reducing environment.
2 Materials and methods
2.1 Chemicals
Water, CH3CN, TFA, and formic acid (FA) were purchased
from Romil (Cambridge, UK). Formaldehyde (37% wt. solu-
tion in H2O) was purchased from Baker. Formaldehyde-d2
(20% wt. solution in D2O), acetaldehyde 99%, acetaldehyde-
d4 98%, sodium cyanoborohydride, triethylammonium bi-
carbonate (TEAB) solution, tetraethylammonium acetate
(TEAOAc), sodium acetate (NaOAc), o-methyl isourea sulfate,
D,L-DTT, iodoacetamide, adrenocorticothropic hormone frag-
ment 18–39 (ACTH), and renin substrate tetradecapeptide
human (TDP) were purchased from Sigma (St. Louis, MO,
USA). Peptide standard mix for MALDI-TOF calibration and
-cyano-4-hydroxycinnamic acid (HCCA) were purchased
from Bruker-Daltonics (Bremen, Germany). Sequencing
grade modified trypsin was purchased from Promega (Madi-
son, WI, USA). Peptides GTFTASQNYLR, SIHVDIYSFPK,
SLEVTFTPVIEDIGK, and EITFTVLASR were purchased
from PSL GmbH (Heidelberg, Germany).
2.2 Peptides synthesis
Peptides 5–9were synthesizedby afluorenylmethoxycarbonyl
(Fmoc)/tert-butyl (tBu) solid-phase peptide strategy as previ-
ously reported [31], purified to homogeneity by preparative
reverse-phase HPLC, and characterized by ESI-MS-HPLC.
2.3 In solution digestion
In all steps buffers were chosen in order to avoid the introduc-
tion of other primary amino groups than those of peptides,
thus no TRIS or primary ammonium salts were employed
during sample treatment. 1.3 L of 0.1 M DTT, 1.5 L of
0.2 M iodoacetamide, and again 0.25 L of 0.1 M DTT were
subsequently added to 15 L (100 g) of a solution of BSA
in 0.1 TEAB M, leaving the mixture for 1 h at 37°C, 1 h at
room temperature in dark, and 20 min at 37°C, respectively.
Samples were digested over night at 37°C by adding 2 L of
trypsin (0.5 g/L) quenching with 2 L of 1% TFA.
2.4 Guanidination
Ten microliters of o-methyl isourea solution (0.5 M) were
added to 10 L of a peptide solution (1 mg/mL) in a
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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0.2mL eppendorf tube at 60°CandpHwas adjusted to 11with
1 L of 2 M NaOH. The reaction was kept at 60°C for 1 h
and quenched with 1 L of TFA 10%.
2.5 Reductive amination
As a general procedure for standard peptides labeling, 50 L
of reaction buffer (0,1 M) were added to 10 L of peptide
solution (1 mg/mL) in a 0.2 mL eppendorf tube. 2.5 L of
NaCNBH3 (1 M) were added and the solution vortexed for
30 s, then 2.5 L of formaldehyde solution (0.5 M) were
added and the mixture vortexed again. After 1 h incubation at
25°C, the reaction was quenched with 2 L of 10% ammonia
solution to consume the excess of formaldehyde.
Ethylationwas carried onwith the same procedure, using
20% acetaldehyde solutions and extending the reaction time
up to 6 h at 30°C. After the first 4 h incubation, a further
addition of both acetaldehyde and NaCNBH3 (2.5 L each)
was necessary to reach completeness.
2.6 Chromatography and MS
Before MALDI analysis all samples have been desalted by
ZipTip-C18 (Millipore P10 size) using a 50% CH3CN/0.1%
TFA solution and a 0.1% TFA solution to wet and equili-
brate/wash the stationary phase, respectively. Peptides were
eluted on the MALDI target with a solution of HCCA
(5 mg/mL in 50% CH3CN/0,1% TFA). MALDI and LC-
MALDI experiments were performed on an UltraFlex III
MALDI-TOF/TOFmass spectrometer (Bruker-Daltonics), ac-
quiring data in positive reflectron mode. Acquisitions were
performed in the mass range 200–3000 m/z with voltages of
25 and 21.7 kV for the first and second ion extraction stages,
9 kV for the lens, 26.3 and 13.8 kV for reflector 1 and 2, re-
spectively. For CID acquisition, the instrument was switched
in LIFT mode; precursor ions were manually selected for
the subsequent fragmentation.MS/MS spectrawere acquired
with 4–8 × 103 laser shots using the instrument calibration
file. MS and MS/MS data were processed and analyzed by
the Bruker FlexAnalysis 3.0 software.(Bruker-Daltonics) op-
erating baseline subtraction, smoothing (Savitsky–Golay) and
centroiding.
LC-MALDI experiments were performed on some deriva-
tized synthetic peptides only, with aDionexUltimate capillary
HPLC system equippedwithUVdetector withU-ZViewCap-
illary flow cell, Famos autosampler, Switchos microcolumn
switching device and Probotmicro fraction collector (LCPack-
ings, Amsterdam, The Netherlands).
Ten micrograms of reaction mixture were desalted for
3 min with 0.1% TFA on a -precolumn cartridge C18
PepMap100 (5 mm, 300 m id, 5 m p.s. LC-Packing) at
a flow rate of 0.030 mL/min. Gradient elution was performed
on a C18 Acclaim PepMap100 (25 cm, 300 m id, 5 m p.s.
LC-Packings) kept at 30°C. A linear gradient from 0 to 35% B
in 60min was applied at a flow rate of 3L/min using the fol-
lowing mobile phases: (i) 0.1% FA and 5% CH3CN; (ii) 0.1%
FA and 95% CH3CN. The Probot spotting device was in-line
interfaced with the UV cell output in order to automatically
mix the eluate with a matrix solution (HCCA, 5 mg/mL in
50%CH3CN/0,5% TFA) and to collect it on theMALDI target
with a 30 s interval between each spot.
LC-MS experiment for quantitation were performed on
a Waters nanoAquity UPLC system interfaced with a Wa-
ters Q-TOF Premier mass spectrometer equipped with a na-
noESI source operating in positive mode. One microgram
of BSA digest was trapped on a Symmetry C18 column
(180m× 20mm, 5mp.s.,Waters) andwashed for 3min at
0.3 L/min with 0.1% TFA. Elution was performed using a
45 min gradient with a flow rate of 250 nL/min (from 0
to 35% CH3CN) on a BEH130 C18 nanoLC column (25 cm
75mid, 1.7mp.s.,Waters). Eluent Awas 0.1%FA and elu-
ent B 0.1% FA in CH3CN. The column temperature was set
at 35°C. Lock mass ([Glu1]-fibrinopeptide B, 250 fmol/L)
was constantly infused by the nanoAcquity auxiliary pump
at a flow rate of 250 nL/min. The mass spectrometer was
set to perform automated data-dependent acquisition select-
ing five precursors for every MS survey scan. Source capil-
lary voltage was set to 2.6 kV, temperature: 90°C, cone gas:
25 L/h, nano flow gas: 0.62 bar. Analyzer was set to operate
in the Vmode. Survey scans were acquired in the mass range
200–1800 m/z with a scan time of 0.8 s and an interscan de-
lay of 0.1 s. MS/MS scans were acquired in the mass range
200–2200 m/z with the same scan rate as the survey scans. A
dynamic exclusion window was set to 30 s.
2.7 Data bank search and quantitation
LC-MS/MS data were processed using the Mascot Distiller
package; default processing options were applied. Databank
searches were performed within the SwissProt database (re-
leased version: 2012_09) selecting “other mammalia” as
taxonomic restriction. Precursor tolerance of 20 ppm and
fragment tolerance of 0.1 Da were set. Cysteine car-
bamidomethylation and methionine oxidation were set as
fixed and variable modification, respectively; according to the
sample the specific modifications induced by the labeling
strategy were considered as variable. Dimethyl (K), dimethyl
(N-term), dimethyl:2H(4)(K), dimethyl:2H(4) (N-term), di-
ethyl (K), diethyl (N-term), diethyl:2H(8) (K); diethyl:2H(8)
(N-term) were selected among the Mascot Server panel. Four
supplemental modifications regarding the imidazolidinone
derivatives observed in the methylation and ethylation reac-
tions were edited using the configuration editor of theMascot
Server. Relative quantitative analysis were carried out mea-
suring the ratio between the signals of light and heavy labeled
peptides (L/H) in the mass spectra, using the Quantitation
Tool ofMascotDistiller.Di-methylation anddiethylationwere
pre-existing quantitationmethods while two furthermethods
were edited to perform the quantitation of the imidazolidi-
none derivative in methylation reactions.
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
1262 S. Levi Mortera et al. Electrophoresis 2014, 35, 1259–1267
3 Results and discussion
Early tests have been performed with nondeuterated reagents
only, on four synthetic proteotypic peptides from mouse
plasma proteins, and two commercially available nontryp-
tic peptides: GTFTASQNYLR (1, exact mass [EM]: 1256.6),
EITFTVLASR (2, EM: 1135.6), SIHVDIYSFPK (3, EM:
1304.7), SLEVTFTPVIEDIGK (4, EM: 1646.9), DRVYIHPFH-
LVIHN (renin substrate tetradecapeptide human, TDP, EM:
1758.9), and RPVKVYPNGAEDESAEAFPLEF (adrenocorti-
cothropic hormone fragment 18–39, ACTH, EM: 2464.2).
Peptides 1, 2, and TDP present a single reactive site at the
N-terminus, while peptides 3 and 4 contain a C-terminal ly-
sine that provides a further derivatizable amino group, and
ACTH features an internal lysine together with an arginine
and a tyrosine, both close enough to be possibly involved in
intramolecular cross-links [19]. All the final reactionmixtures
were analyzed by MALDI-TOF-MS to verify the presence of
the desired product and the complete absence of the starting
material.
3.1 Preliminary observations
In a preliminary experiment dimethylationwas performed on
TDP and ACTH by adding formaldehyde prior to NaCNBH3
and using 0.1 M TEAB (pH 8.8) as reaction buffer. With
TDP we observed two partially overlapped signals in the
MALDI spectrum, corresponding to the expected dimethy-
lated product ([M+H]+: 1787.9 m/z), with a mass increase of
28 Da, and to a much less abundant side product featuring
2 mass units less (Supporting Information Fig. 1). A 26 Da
mass increment is consistent with a rearrangement involv-
ing the Schiff-base to generate an imidazolidinone derivative
at the N-terminus with the formation of a methylene bond
that implies the loss of two hydrogens [22] (Fig. 1). In the
same conditions the signal of a secondary product with a
52 Da mass increase is observed with ACTH, besides the
signal of the expected tetra-methylated peptide (m = +56
Da, [M+H]+: 2521.3 m/z; Supporting Information Fig. 2).
In this case the apparent loss of four hydrogens can be as-
cribed to the formation of two methylene bridges in an in-
tramolecular cross-link that probably involves the Lys4 and the
N-terminal arginine [16] (Fig. 2). Interestingly, the adduct for-
mation is almost completely suppressed when formaldehyde
is added after NaCNBH3, namely when the imine is formed
in a preexistent reducing environment. No side products have
been observed performing the derivatization in acidic condi-
tions, using a 0.1 M NaOAc buffer (pH 5.3), whereas a small
+26 Da signal is still visible in the MALDI spectrum of TDP
at neutral pH (6.9) with 0.1 M TEAOAc.
Derivatization of TDP and ACTH with acetaldehyde has
been set upmodifying the protocol adopted by Boersema et al.
with formaldehyde. Reaction time is noticeably longer with
respect to methylation, due to the reduced electrophilicity of
the Shiff-base, and completeness is achieved, at pH 5.3, af-
ter 6 h incubation at 30°C. In this case, higher pH values
Figure 1. The N-alkyl-4-imidazolidinone derivative can be gen-
erated by the nucleophilic addition of the contiguous peptidic
nitrogen to the Shiff-base before it can be reduced by hydride.
produce either the formation of a side product and a further
slowdown of the reaction. Indeed a +54 Da product becomes
evident with TDP, partially overlapped with the expected
+56 Da diethylated compound ([M+H]+: 1815.9 m/z), be-
coming even the most abundant observed when 0.1 M TEAB
(pH 8.5) is employed as reaction buffer (Supporting Informa-
tion Fig. 1). In any condition no secondary product is detected
with ACTH beside the expected tetra-ethylated compound
([M+H]+: 2576.3m/z). In this case the imidazolidinone rear-
rangement is forbidden while the intramolecular cross-link
is probably prevented by steric reasons (Supporting Informa-
tion Fig. 2).
3.2 Investigation on side products nature
The peculiar modification observed on ACTHwith formalde-
hyde was studied more in detail by means of five ad hoc syn-
thesized decapeptides designed to reproduce its presumed
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Figure 2. Possible reaction paths for ACTH in the reaction with formaldehyde. Intramolecular cross-link reactions can take place if
NaCNBH3 is added after a while.
reactive region. RPVKVYPNGA (5, EM: 1099.6) was pre-
pared to replicate the same sequence of ACTH from the
N-terminus to the Ala10, while its N-protected homologous,
AcRPVKVYPNGA (6, EM: 1141.6), was thought to restrict the
derivatization to Lys4. With APVKVYPNGA (7, EM: 1014.6)
and AcAPVKVYPNGA (8, EM: 1056.6) we aimed at prevent-
ing the intramolecular cross-link by replacing Arg1 with Ala,
while AcAPVKVAPNGA (9, EM: 964.5) features the replace-
ment of Tyr6 with Ala, eliminating a further possible residue
that could be involved in a reaction with the dimethylated
Lys4 (Fig. 2).
A mixture of peptides 1–5 was submitted to reductive
amination either with formaldehyde and acetaldehyde chang-
ing four different buffers: NaOAc (0.1 M, pH 5.3), TEAOAc
(0.1 M, pH 6.9), TEAB (0.1 M, pH 8.0), and TEAB (0.1 M,
pH 8.8). In MALDI spectra we observed a general trend in ac-
cordance with our early experiments, detecting the presence
of a side product increasing pH, again with a much higher
easiness with acetaldehyde than with formaldehyde. Signals
of the +26 or +54 Da products in the reaction with formalde-
hyde become perceptible at basic pH and, from a rough es-
timation, are always below 10% intensity with respect to the
desired di- or tetra-methylated products. In the ethylation ap-
proach these signals are instead clearly visible yet at pH 7.0
and can become almost exclusive above pH 8.0. In the case
of 5, long incubation time in a basic environment seems also
to give partial deamidation of Asn8 (Fig. 3). It is clear that the
chemical environment of the primary amino groups plays a
crucial role in regulating the competition between the inter-
molecular addition of hydride and other intramolecular or
intermolecular nucleophilic attacks to the generated imine.
Peptide 1 yields quite only the expected product ([M+H]+
1285.6m/z) in the reactionwith formaldehyde andNaCNBH3
even at basic pH, while in the reaction with acetaldehyde the
signal intensity of the side product ([M+H]+ 1311.7 m/z) is
about 5% at pH 8.0 and slightly increases at pH 8.8. On the
other hand, a small amount of secondary product is visible
when formaldehyde reacts with peptides 2, 3, and 4 at pH 8.0
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
1264 S. Levi Mortera et al. Electrophoresis 2014, 35, 1259–1267
Figure 3. MALDI spectra
showing different behavior of
peptides 1–5 in the reductive
amination with acetaldehyde.
The expected di- or tetra-
ethylated products are tagged
with empty symbols. Side
products signals (color filled
symbols) increase in intensity
and can even become the
main ones while reactions
slow down.
but it becomes considerable with acetaldehyde. Such prod-
ucts are the main ones at pH 8.8, where completeness is not
always achieved even after 6 h incubation (see Fig. 3).
To get a first indication about the side-reaction location
the 2MEGA approach was applied on peptides bearing a ly-
sine. If a cyclization at the N-terminus occurred, it should
be observed as well when lysine is guanidinated before the
dimethylation step at pH 8.0, and indeed a +26 Da signal
is still detectable in the MALDI mass spectra of peptides
3 and 4.
Both dimethylation and diethylation were performed on
peptides 5–9 adding the aldehydes before NaCNBH3 in order
to let the possible cyclization between Arg1 and Lys4 be fa-
vored, and the side product be more perceptible in the mass
spectra (Supporting Information Fig. 3). In the reaction with
acetaldehyde, we never observed the formation of a cross-link
product even if the reducing agent was added 3 h after the
introduction of acetaldehyde at pH 8.5. Steric hindrance is
probably the main reason for this difference with dimethyla-
tion, together with an apparent overall reduced reactivity.
Peptide 5 behaves exactly as ACTH in the reaction with
formaldehyde, thus a couple of products (+56 Da: [M+H]+
1156.6 m/z, +52 Da: [M+H]+ 1154.6 m/z) is observed only
above pH 8.0. Similarly, 6 yields the expected dimethylated
product ([M+H]+ 1170.6 m/z) together with the respective
side product with 4 mass units less. A single tetra-methylated
product is observed with 7 ([M+H]+ m/z), while 8 and 9 give a
single dimethylated derivative at the lysine residue ([M+H]+
1085.6 m/z and [M+H]+ 993.6 m/z, respectively). All the
mass shift observed in the dimethylation, diethylation, and
2MEGA approaches with peptides 1–9 are summarized in
Table 1.
It was very surprising to detect the occasional appear-
ance of a +26 Da signal in the MALDI spectra of peptides
5–9 after reaction with formaldehyde either at basic and
acidic pH. (Supporting Information Fig. 4) As no evidence
of a corresponding product is found in the ESI-MS spectra,
this phenomenon seems to be related to a rearrangement
that could take place directly in the MALDI source (Fig. 4).
Laser desorption is known to be “harder” than ESI, so what
we observed was probably the loss of two hydrogens by the
produced tertiary amine to generate an immonium ion that
gives a [M−H]+ signal [32] (Supporting Information Fig.
5). Slight differences have been observed by changing the
MALDI matrix, but anyway we did not succeed in control-
ling the reaction probably because it is not driven by a single
factor (data not shown). This immonium ion rearrangement
seems anyway to be a really unpredictable andunreproducible
Table 1.Mass increments (amu) observed in the MALDI spectra of reaction products at two different pH values
Peptide
Reaction Dimethylation 2MEGA Diethylation
pH 5.5 pH 8.5 pH 5.5 pH 8.5 pH 5.5 pH 8.5
GTFTASQNYLR (1) 28 28, 26 — — 56 56, 54
EITFTVLASR (2) 28 28, 26 — — 56 56, 54
SIHVDIYSFPK (3) 56 56, 54 70 70, 68 112 112, 110
SLEVTFTPVIEDIGK (4) 56 56, 54 70 70, 68 112 112, 110
RPVKVYPNGA (5) 56 56, 52a) 70 70 112 112
AcRPVKVYPNGA (6) 28 28, 24a) — — 56 56
APVKVYPNGA (7) 56 56 70 70 112 112
AcAPVKVYPNGA (8) 28 28 — — 56 56
AcAPVKVAPNGA (9) 28 28 — — 56 56
a) Observed only if formaldehyde is added before NaCNBH3.
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
Electrophoresis 2014, 35, 1259–1267 Liquid Phase Separations 1265
Figure 4. Chromatogram and MALDI-CID spectra of the two products of reductive dimethylation of 3. (A) First eluted compound. (B)
Second eluted compound.
Figure 5. The [M−H]+ signal
observed in the MALDI-TOF
spectrum of dimethylated 8
(left) is not present in the ESI-
QTOF spectrum of the same
reaction mixture (right).
phenomenon that generates a small amount of subproduct
and could be considered a minor hitch in quantitative anal-
ysis by MALDI experiments only. LC-MALDI experiments
were performed with a few reaction mixture of single syn-
thetic peptides, where a side product was detected, aiming
at verifying if the apparent [M-H]+ signal could be referred
to the imidazolidinone derivative or to the “in source” gen-
erated immonium ion. The CID spectra of the two-reaction
product of 3, give a further indication about the location of
the rearrangement. In theMS/MS spectrumof the first eluted
product (tetramethylated 3, [M+H]+ 1361.7m/z) the expected
enhancement of the a1 ion is observed [33], the y series is com-
pletely detected, and in the b series the b1 ion misses. The y
sequence is exactly the same in the spectrum of the second
eluted compound ([M+H]+ 1359.7 m/z), whereas all the b
ions are shifted by 2 mass units (Fig. 5).
3.3 Quantitation
Although we outlined here how reaction conditions can
be optimized to reduce or completely suppress such un-
wanted products on standard peptides, an initial evaluation of
their impact in quantitation experiments has been attempted
with a BSA digest. Differential labeling was performed
with formaldehyde at both acidic and basic pH, mixing the
two final solutions in a 5:2 ratio. Quantitative analysis by
LC-MS/MS experiments yielded in both cases L/H values
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Table 2.Mascot Distiller quantitation reports for differential BSA labeling with formaldehyde at two different pH values
BSA pH 5.5 pH 8.5
Score L/HTa) L/HEb). SDgc) Score L/HTa) L/HEb) SDgc)
1291 2.5 2.52 1.12 1051 2.5 2.47 1.13
Peptide sequence L/H SD z m/z Score L/H SD z m/z Score
CCAADDKEACFAVEGPK 2.6 0.04 3 675.32 54.9
CCTESLVNR 2.6 0.01 2 583.75 47.6
DAFLGSFLYEYSR 2.5 0.01 2 798.37 74.7 2.3 0.02 2 798.39 62.2
DDPHACYSTVFDK 2.7 0.07 3 537.58 39.9
DDSPDLPK 2.5 0.05 2 471.74 26.3
DLGEEHFK 2.3 0.05 3 344.17 14.9
DLGEEHFK 2.4 0.06 2 515.76 31.3
ECCHGDLLECADDR 2.5 0.03 3 593.23 76.6 2.5 0.01 3 593.23 76.5
ECCHGDLLECADDRADLAK 2.9 0.03 3 768.66 55.5
EYEATLEECCAK 2.8 0.03 2 779.84 68.1 2.9 0.03 2 779.83 68.9
GLVLIAFSQYLQQCPFDEHVK 2.9 0.07 3 850.12 48.6 2.2 0.01 3 850.10 78.8
KQTALVELLK 2.6 0.03 2 613.90 26.7
KVPQVSTPTLVEVSR 2.9 0.04 2 565.99 56.1
LCVLHEK 2.1 0.02 2 481.79 44.2
LFTFHADICTLPDTEK 2.2 0.06 3 655.32 43.5 2.3 0.03 3 655.33 33.5
LGEYGFQNALIVR 2.5 0.03 2 754.41 44.8
MPCTEDYLSLILNR 2.6 0.04 3 584.96 42.6 2.5 0.06 3 584.95 39.8
MPCTEDYLSLILNR 2.8 0.04 2 876.93 70.0 2.7 0.06 2 876.93 54.1
QNCDQFEK 2.6 0.03 2 562.75 54.9 1.9 0.04 2 566.77 45.1
QTALVELLK 1.8 0.03 2 539.86 62.4 2.2 0.01 2 539.86 54.2
RHPYFYAPELLYYANK 2.6 0.05 3 701.03 38.2 2.9 0.06 3 701.02 38.0
SLHTLFGDELCK 2.5 0.05 2 738.38 71.8
TCVADESHAGCEK 2.5 0.01 2 760.33 68.7
TVMENFVAFVDK 2.5 0.03 2 728.37 71.1 2.0 0.07 2 732.40 52.7
YICDNQDTISSK 2.2 0.02 2 754.37 104.2 2.7 0.01 2 750.35 75.6
Identified peptide pairs with evident outlier L/H values or with SD > 0.1 were excluded from the analysis.
a) Theoretical L/H.
b) Experimental L/H.
c) Geometric standard deviation.
in great accordance with the theoretical values and simi-
lar protein sequence coverage (Table 2). No evidences of
side-products effects rose from these results, and indeed
very few peptides were detected when the imidazolidinone
rearrangement was set as fixed modification in the Mascot
search. Concerning the reaction carried on at pH 8.5, accord-
ing with the standard error threshold that we set to perform
quantitation (SD  0.1), only two peptide pairs were suit-
able to the analysis; however, yielding a L/H slightly below
the theoretic value (Supporting Information Table 1). Per-
forming the diethylation labeling on BSA digest at pH 5.5,
7.0, and 8.5 we could not achieve reliable quantitation re-
sults, as in any case the analysis yields L/H values varying
a lot from one peptide to another and being often largely
above the expected value. Nevertheless, we definitely identi-
fied several peptides bearing the imidazolidinone rearrange-
ment yet at neutral conditions, frequently associated to a high
score.
4 Concluding remarks
Withourworkwe aimed at rationalizing the various ensemble
of publishedprocedures for reductive amination, pointing out
the issue of side reactions on the base of some observations on
standard peptides. We showed that the undesired occurrence
of side products is easier than as reported when pH is main-
tained above 7.0, either with formaldehyde and much more
manifestly with acetaldehyde. We anyway demonstrated that
working with formaldehyde, in a pH range that includes all
the conditions reported in the literature (pH 5–8.5), should
not bring to any significant drawback when attempting quan-
titation on a more complex sample. On the other hand, we
are also able to state that diethylation brings to large amounts
of side product featuring N-terminal cyclization, when per-
formed at basic pH, but also at neutral conditions. Al-
though the real impact on quantitationmust be still evaluated
with experiments on more complex samples, our work has
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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disclosed some crucial aspects of the labeling procedure that
have never been taken into consideration before.
By a chemical point of view the observations on ACTH
or its mimicking peptides 5–9 toward formaldehyde are un-
doubtedly peculiar and interesting but, fortunately, such re-
arrangements should be very uncommon when a tryptic di-
gest is subjected to reductive amination. An intramolecular
cross-link between arginine and lysine can take place only if
a miscleavage occurs or if Lys-C is used for digestion. More-
over, both residues must be localized at a proper distance
each other in the peptide sequence.
Our study has partially highlighted how complex the sce-
nario can be when we undertake a derivatization task on a
complex ensemble of substrates. In our experiments, we have
shown that reductive amination on tryptic peptides leads to
the desired dimethylation, or diethylations, at N-termini and
at lysine residues only when pH ensures a rapid action of
the hydride and reduces the nucleophilicity of other amino
groups. With these initial evidences, based on our controlled
model experiments, we cannot describe a comprehensive pro-
teome picture, ormake an assessment of the residues that are
more likely to promote a rearrangement at the N-terminus, or
even spot-out the lysine residuesmore likely involved in cross-
links. A further more extensive and systematic investigation
could be interesting to widen the knowledge on aldehyde-
induced modification on peptides and proteins.
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